LabConnect, Cryoport Partner to Support Triumvira Trial Logistics

Will integrate Cryoport's Cryoportal Logistics Management Platform and LabConnect's SampleGISTICS platform to provide Triumvira with advanced logistics support.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

LabConnect, Inc. and Cryoport, Inc. have partnered to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc., a biopharma company developing a novel platform for engineering T cells to attack cancers. The study will investigate the safety and efficacy of autologous TAC-T Cells (TAC01-HER2) targeting HER2 in relapsed or refractory solid tumors.   The partnership will integrate Cryoport’s Cryoportal Logistics Management Pl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters